ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

NAMSW NewAmsterdam Pharma Company NV

7.46
0.00 (0.00%)
Pre Mercado
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
NewAmsterdam Pharma Company NV NAMSW NASDAQ Warrant Capital Accionario
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 7.46 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
7.46
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
11/6/202407:12EDGAR2Form 8-K - Current report
11/6/202407:00GLOBENewAmsterdam Pharma Announces Issuance of Composition of..
07/6/202415:15EDGAR2Form 8-K - Current report
07/6/202415:01GLOBENewAmsterdam Pharma Reports Inducement Grants Under Nasdaq..
29/5/202407:00GLOBENewAmsterdam Pharma to Participate in Upcoming Investor..
21/5/202407:00GLOBENewAmsterdam Pharma to Present New Clinical and Preclinical..
09/5/202415:18EDGAR2Form ARS - Annual Report to Security Holders
09/5/202415:15EDGAR2Form DEF 14A - Other definitive proxy statements
09/5/202407:00EDGAR2Form 8-K - Current report
09/5/202407:00GLOBENewAmsterdam Pharma Provides Corporate Update and Reports..
08/5/202415:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/5/202415:01GLOBENewAmsterdam Pharma Reports Inducement Grants Under Nasdaq..
02/5/202407:00GLOBENewAmsterdam Pharma to Host R&D Day with Key Opinion Leaders..
09/4/202407:00GLOBENewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal..
01/4/202407:00GLOBENewAmsterdam Pharma Announces the Appointment of Juliette..
25/3/202407:00GLOBENewAmsterdam Pharma to Present New Analysis from the Phase 2..
12/3/202407:00GLOBENewAmsterdam Pharma Doses First Patient in Phase 3 TANDEM..
28/2/202407:00GLOBENewAmsterdam Pharma Reports Full Year 2023 Financial Results..
26/2/202407:00GLOBENewAmsterdam Pharma to Participate in Upcoming Investor..
13/2/202421:40GLOBENewAmsterdam Pharma Announces Pricing of $175.3 Million..
13/2/202415:01GLOBENewAmsterdam Pharma Announces Commencement of Public..
01/2/202415:01GLOBENewAmsterdam Pharma to Present at Guggenheim Healthcare..
08/1/202407:00GLOBENewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A...
04/1/202407:00GLOBENewAmsterdam Pharma Announces 2024 Strategic Priorities
13/11/202307:00GLOBENewAmsterdam Pharma Provides Corporate Update and Reports..
23/10/202307:00GLOBENewAmsterdam Pharma Announces Appointment of Ian Somaiya as..
21/9/202306:00GLOBENewAmsterdam Pharma Announces Initial Data from Phase 2a..
20/9/202307:00GLOBENewAmsterdam Pharma to Present at 2023 Cantor Fitzgerald..
14/8/202315:01GLOBENewAmsterdam Pharma Announces Appointment of William “BJ”..
07/8/202306:15GLOBENewAmsterdam Pharma Provides Corporate Update and Reports..
25/7/202315:01GLOBENewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3..